Back to companies
Xenon Pharmaceuticals Inc.
XENECANASDAQPharmaceuticals & HealthcareXenon Pharmaceuticals Inc.
Revenue
$7.5mn
FY2025
Operating income
-$373.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API